Crystalline forms of therapeutic compounds and uses thereof

Chemical Process for Preparing Imidazopyrrolidinone Derivatives and Intermediates Thereof

Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide for treating diffuse large B-cell lymphoma

Solid forms of an FGFR inhibitor and processes for preparing the same

Formulations of a compound modulating kinases

TYK2 inhibitors, uses, and methods for production thereof

[1,2,4] triazolo [1,5-a] pyridine derivative and crystalline form thereof

PROCESS FOR PREPARATION OF DACLATASVIR AND SALTS

Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereof

Polymorphs of herbicidal sulfonamides

PROCESS FOR THE PREPARATION OF SODIUM 4-(2-((1E,3E,5E,7Z)-7-(1,1-DIMETHYL-3-(4-SULFONATOBUTYL)-1H-BENZO[e]INDOL-2(3H)-YLIDENE) HEPTA-1,3,5-TRIENYL)-1,1-DIMETHYL-1H-BENZO[e]INDOLIUM-3-YL) BUTANE-1-SULFONATE (INDOCYANINE GREEN)

Solid porous form of trimesic acid and a process for preparation thereof

Crystalline forms of selinexor and process for their preparation

SYSTEMS AND METHODS FOR SEPARATING MIXTURES COMPRISING FLUOROCARBOXYLIC AND CARBOXYLIC ACIDS

Gremlin-1 antibody

Crystalline polymorphic form of 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-OXO-2λ5-[1,2]oxaphosphinane

Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same

Solid state forms of ixazomib citrate

Pyrrolopyrimidine crystal for preparing JAK inhibitor

Pyrroloquinoline quinone monosodium and method for producing the same, and composition comprising the same

Rotigotine behenate, and manufacturing method and application thereof

Crystalline forms of a bromodomain and extraterminal protein inhibitor drug, processes for preparation thereof, and use thereof

Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders

Process for the preparation of docosanol

Low dose compositions of Aramachol salts

Compounds

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carb oxamide and solid state forms thereof

Crystalline forms of AP26113, and preparation method thereof

Solid state forms of apalutamide

Dopamine D1 receptor positive allosteric modulators

MONO-(ACID) SALTS OF 6-AMINOISOQUINOLINES AND USES THEREOF

Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt

Amorphous Trisodium Sacubitril Valsartan and process for its preparation

Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof

Processes for the preparation of (3S,4R)-3,ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Purinone derivative hydrochloride

Crystalline valbenazine free base

Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate

Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof

Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

Crystal forms and production methods thereof

Method for preparing L-methionine crystals using crystallization technique

Solid forms of an adamantyl compound, compositions and uses thereof

METHOD FOR PRODUCING N-(ALPHA-HYDROXYETHYL)FORMAMIDE AND METHOD FOR PRODUCING N-VINYLFORMAMIDE

5-bromo-2-(alpha-hydroxypentyl)benzoic acid sodium salts in different crystal forms, and preparation method thereof

Manufacture of bisphenol A

PROCESS FOR THE PREPARATION OF HU-910 AND CRYSTALLINE STRUCTURE THEREOF

Acetate salt of buprenorphine and methods for preparing buprenorphine

Polymorph of sodium neridronate and preparation process thereof

Topical Pharmaceutical Formulations For Treating Inflammatory-Related Conditions

Hydrobromide of benzodiazepine derivative, preparation method and use thereof

Salts and processes of preparing a PI3K inhibitor

Crystalline salts of peptide epoxyketone immunoproteasome inhibitor

Crystalline forms and processes for the preparation of cannabinoid receptor modulators

Salts of 2,6-dimethylpyrimidone derivatives and uses thereof

Complexes of Celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them

Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide

Methods of synthesizing substituted purine compounds

METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS

Crystal forms of lifitegrast

Salt of quinazoline derivative, preparation method therefor and application thereof

POLYMORPHS OF BETRlXABAN & ITS MALEATE SALT

Solid forms of cannabidiol and uses thereof

Acetate salt of buprenorphine and methods for preparing buprenorphine

Crystal salt form of 2,2-dimethyl-6-((4-((3,4,5-trimethoxyphenyl)amino)-1,3,5-triazine-2-yl)amino)-2H-pyrido[3,2-b][1,4]oxazine-3(4H)-one for human use

Solid forms of TTK inhibitor

Methanesulfonate polymorph of 5-type phosphodiesterase inhibitor and preparation method and applications thereof

Process for the preparation of dasatinib polymorph

N-PALMITOYL-D-GLUCOSAMINE IN A MICRONIZED FORM

Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Process for purification of malonic acid from fermentation broth

Crystal form of dapagliflozin intermediate and preparation method therefor

Soft gelatin capsule formulation

Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same

Crystal of DPP-IV long-acting inhibitor and salt

M-dihydroxybenzene derivative crystal and salt, and manufacturing method thereof

Process for preparing a clomazone, novel form and use of the same

Fenfluramine compositions and methods of preparing the same

Stable amorphous form of sacubitril valsartan trisodium complex and processes for preparation thereof

Dry-mode oil/fat separation method

Process for the preparation of 1,5-benzothiazepine compounds

CRYSTAL AND SALT OF NITROIMIDAZOLE, AND MANUFACTURING METHOD THEREOF

Crystalline form of (1R,2R)-2-[4-(3-methyl-1H-pyrazol-5-yl)benzoyl]-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazin-3-yl)cyclohexanecarboxamide

Crystalline form of GnRH receptor antagonist and preparation method therefor

CHIRAL RESOLUTION OF AN INTERMEDIATE OF SUVOREXANT AND COCRYSTALS THEREOF

CRYSTAL OF QUINOLINE DERIVATIVE

Processes and intermediates for the preparation of Pimavanserin

Crystalline forms of apremilast

POLYMORPH OF NINTEDANIB

Crystalline forms of therapeutic compounds and uses thereof

Solid forms of an antiviral compound

Polymorphic forms of triazolopyrazine derivatives and method of preparing the same

Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid

Polymorphs of Dasatinib

Solid forms of (R)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

Salts of a Pim kinase inhibitor

Polymorph of triaryldimethylpiperazine dihydrochloride and preparation method and application thereof

Process for the purification of 1-(4-chlorophenyl)pyrazol-3-ol

Fenofibrate crystalline form and manufacturing method thereof

(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid

PHARMACEUTICAL COMPOSITIONS COMPRISING POLYMORPHIC FORMS ALPHA, BETA, AND GAMMA OF RIFAXIMIN

POLYMORPHIC FORMS ALPHA, BETA AND GAMMA OF RIFAXIMIN

Process for the preparation of umeclidinium bromide

Crystalline forms

Naphthyridinone derivatives and their use in the treatment of arrhythmia

Method for producing crystal of uracil compound

Method for producing 2-acetyl-4H,9H-naphtho[2,3-B]furan-4,9-dione

Crystalline forms of neurotrophin mimetic compounds and their salts

Crystalline forms of Lesinurad

Co-crystals of substituted glycine and uses thereof

POLYMYXIN B SULFATE CRYSTAL AND PREPARATION METHOD THEREOF

Crystalline metal organic framework

Salts, crystal forms, and production methods thereof

PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS OF HYDROCODONE BENZOIC ACID ENOL ESTER AND PROCESSES FOR MAKING SAME

Compounds useful as inhibitors of ATR kinase

Crystalline forms of PLX3397 hydrochloride, processes for preparation and use thereof

Salts of quinazoline derivative or crystals thereof, and the process for producing thereof

CRYSTALLINE FORMS OF DACLATASVIR DIHYDROCHLORIDE

CRYSTALS OF ANILINE PYRIMIDINE COMPOUND SERVING AS EGFR INHIBITOR

Crystal purification

Crystal forms of lenvatinib

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

COMPOSITIONS FOR MODULATING A KINASE CASCADE AND METHODS OF USE THEREOF

Crystalline form II of dextral oxiracetam, preparation method therefor and use thereof

Crystalline pharmaceutical co-crystals of glycopyrronium bromide with lactose

Crystalline forms of eravacycline

Vitamin D Compounds and Methods for Preparing Same

Method for removing residual organic solvent from a crystalline oligosaccharide

Crystalline forms of mitomycin C for treatment of cancer

CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR

CRYSTALLINE FORMS OF A BRUTON'S TYROSINE KINASE INHIBITOR

ABT-199 addition salt and crystal form thereof, preparation method thereof, and pharmaceutical composition thereof

Process for the preparation of pure and stable crystalline Raltegravir potassium form 3

Method for purifying benzopyran derivative, crystal form thereof, and method for preparing crystal form

Crystal form of ozanimod hydrochloride and processes for preparation therefor

Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile

Crystalline freebase forms of a biphenyl compound

Crystalline modification of propanil

Solid form of 4′-thio-2′-fluoronucleoside phosphamide compound and preparation method therefor and use thereof

Co-crystal forms of a novobiocin analog and proline

Intermediates and process for the preparation of a crystalline form of a topical anti-inflammatory agent

Galunisertib crystalline form, preparation method thereof and use thereof

Process for the preparation of Ibrutinib

Process for preparation of palbociclib

Pyrimidine compound as JAK kinase inhibitor

Crystalline forms, preparation methods and pharmaceutical compositions of ozanimod

Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine

Crystal forms of a 9-aminomethyl substituted tetracycline compound and a preparation method thereof

Polymorphic forms of belinostat and processes for preparation thereof

Selective bromodomain inhibition of fungal Bdf1

Crystalline bis- and tris-hydrochloride salt of elamipretide

Glucokinase activators and methods of using same

Crystalline forms of tenofovir alafenamide

DIARYL MACROCYCLE POLYMORPH

Polymorphs of rucaparib camsylate and methods of making same

POLYMORPHS

Polymorphic forms of VENCLEXTA

N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-D]pyrimidin-1-YL]-phenyl}-cyclopropanecarboxamide dimethyl sulfoxide solvate as an MEK1/2 inhibitor

Polymorphic forms of kinase inhibitor compound, pharmaceutical composition containing same, preparation method therefor and use thereof

Crystalline form of Olaparib

Pharmaceutical salts N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide and crystalline forms thereof

Crystalline forms of lasmiditan, preparation methods, pharmaceutical compositions and uses thereof

Crystalline diethylamine tetrathiomolybdate and its pharmaceutical uses

Co-crystals of tramadol and coxibs

Crystal of cytidine diphosphate choline and production method thereof

Crystal forms of beta-nicotinamide mononucleotide

Isosulfan blue, its crystalline form and process for preparation thereof

Intermediates in the synthesis of cephalosporin compounds

Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof

Methods of preparing co-crystals of ibrutinib with carboxylic acids

Crystals of [2-(1-methyl-1H-pyrazol-4-yl)-6(morpholin-4-yl)-9H-purin-8-yl][4-(morpholin-4-yl)piperidin-1-yl]methanone and pharmaceutically acceptable salt thereof

Polymorph of an intermediate for palbociclib synthesis

LOW HYGROSCOPIC ARIPIPRAZOLE DRUG SUBSTANCE AND PROCESSES FOR THE PREPARATION THEREOF

Crystalline form of gamma-aminobutyric acid and preparation method thereof

Process for purification of carfilzomib intermediate

Crystal forms and salt forms of 7h-pyrrolo[2,3-d]pyrimidine compounds and preparation method thereof

Crystal form of pyrroloquinoline quinone sodium salt and preparation method and use thereof

Crystal forms of NBI-98854, preparation method and use thereof

Process of making somatostatin modulators

Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione

Dapagliflozin crystal form and preparation method and use thereof

Crystal form B of 1-isobutyryl-1′-((1-(4,4,4-trifluorobutyl)-4,5,6,7-tetrahydro-1H-benzo[d]imidazol-2-yl)methyl)spiro[azetidine-3,3′-indolin]-2′-one

Crystalline form of lenvantinib mesylate and process of preparation thereof

EMM-28, a novel synthetic crystalline material, its preparation and use

Formulations of pimavanserin

TOPICAL THERAPY FOR THE TREATMENT OF SKIN KERATOSES USING NANOPARTICLES OF TAXANES

Crystalline forms of a triazolopyrimidine compound

Synthetic co-crystals of anhydrous guanine and process for preparing the same

Solid state forms of lumateperone ditosylate salt

Solid state forms of Palbociclib dimesylate

Process for producing Lamivudine and Emtricitabine

Antifungal compounds and processes for making

Solid forms of ingenol 3-(3,5-diethylisoxazole-4-carboxylate) and method for preparing the same

Method for producing the crystalline form of modification a of calcobutrol

Compositions of crystallized hydrophobic compounds and methods of making and using same

Crystal of amino acid salt of 3-hydroxyisovaleric acid and production method thereof

Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-l,2-dithiole-3-thione, taste-modified formulations, and methods of making and using same

SALTS OF (S)-7-(1-(9H-PURIN-6-YLAMINO)ETHYL)-6-(3-FLUOROPHENYL)-3-METHYL-5H-THIAZOLO[3,2-A]PYRIMIDIN-5-ONE

Process for producing crystals of a diazabicyclooctane derivative

PROCESSES FOR PREPARATION OF EMPAGLIFLOZIN

Crystal Forms

Crystalline forms of a lysyl oxidase-like 2 inhibitor and methods of making

Crystalline form of sacubitril sodium salt

Solid state forms of linaclotide

Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts

Crystalline forms of therapeutic compounds and uses thereof

Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereof

Pharmaceutically acceptable salt of EGFR inhibitor, crystal form thereof, preparation method therefor and application thereof

Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-C]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide

Salt forms of 4-cyano-n-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide

Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production

Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method therefor

Antifungal compound process

Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof

Polymorphic Forms Of Vortioxetine Hydrobromide Tert-Butanolate

Crystal forms of valsartan disodium salt

Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders

7H-azulene [1,2,3-i,j] isoquinolin-7-one compound, single crystal and use thereof

Salt of (R)-(-methylpyrrolidine--yl)methyl(-chloro--fluoro-[-biphenyl]--yl)carbamate and crystal form thereof

Solvate form of (R)-2-amino-3-phenylpropyl carbamate

5-bromo-2-(alpha-hydroxypentyl)benzoic acid sodium salts in different crystal forms, and preparation method thereof

Sofosbuvir Derivatives for the Treatment of Hepatitis C

Pure heptasulfated disaccharides having improved oral bioavailability

Crystals

Morphic forms of marizomib and uses thereof

Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same

Avibactam free acid

SOLID FORMS OF VENETOCLAX AND PROCESSES FOR THE PREPARATION OF VENETOCLAX

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitors

Crystal of salt of quinazoline derivative

SALTS AND POLYMORPHS OF ESREBOXETINE

Method for resolution of citalopram intermediate 5-cyano diol

Solabegron zwitterion and uses thereof

METHOD FOR RECOVERING TITANIUM (HALO) ALKOXIDE FROM A WASTE LIQUID

Crystalline 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid

DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON'S TYROSINE KINASE

Process for preparing a PARP inhibitor, crystalline forms, and uses thereof

Beta-lactamase inhibitors

PROCESS FOR THE PREPARATION OF VENETOCLAX

Crystalline forms of JAK1-selective inhibitor, processes for preparation and use thereof

Crystalline form of chemical compound, and preparation method, composition, and application thereof

Crystalline hydrate of the compound (2S,3R)-isopropyl 2-(((2-(1,5-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-1-((tetrahydro-2H-pyran-4-yl)methyl)-1H-benzo[D]imidazol-5- yl)methyl)amino)-3-hydroxybutanoate edisylate

Polycrystalline form of dehydrophenylahistin-like compound, and manufacturing and purification method and application thereof

Intermediates and process for preparing intermediates in the production of substituted pyrazolopyridines

Hydrates of substituted 5-fluoro-1H-pyrazolopyridines

Crystal modifications of elobixibat

PROCESS FOR THE PREPARATION OF 5-[[[(2S)-2-AMINO-3-[4-(AMINOCARBONYL)-2,6-DIMETHYLPHENYL]-1-OXOPROPYL] [(1S)-1-(4-PHENYL-1H-IMIDAZOL-2-YL)ETHYL]AMINO] METHYL-2-METHOXYBENZOIC ACID AND ITS POLYMORPHS THEREOF

Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof

Innovative preparation and crystallization of iosimenol

Co-crystals of lithium benzoate and uses thereof

NEW SOLID FORMS OF CANNABIDIOL AND USES THEREOF

Compositions comprising HMOS, their production and use for the prevention and/or treatment of viral and/or bacterial infections

Compounds

Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

Crystal forms of sodium-glucose co-transporter inhibitor, processes for preparation and use thereof

Coordinative alignment of molecules in chiral metal-organic frameworks

Diaryl macrocycles as modulators of protein kinases

Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof

Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride salt

Crystalline solid forms of a BET inhibitor

Salts and crystal forms of diaza-benzofluoranthrene compounds

Solid forms of an sGC stimulator

Method for producing diphenylmethane derivative

Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide

Polymorphs of N-[(6-cyano-2-fluoro)-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide as kallikrein inhibitors

Process for the preparation of DL-proline co-crystal of Dapagliflozin

Vortioxetine pamoic acid salt and crystal form thereof

Crystal forms and production methods thereof

Co-crystals of sodium benzoate and uses thereof

Method of producing terephthalic acid

Polymorphic forms of naltrexone

Solid forms of a compound for modulating kinases

Process for the synthesis of docosanol

Preparation and Uses of Obeticholic Acid

Organotin clusters, solutions of organotin clusters, and application to high resolution patterning

CRYSTAL FORM A OF MILBEMYCIN A3 OXIME AND PREPARATION METHOD THEREOF

Tertiary alcohols as PI3K-γ inhibitors

PI3K inhibitor, and pharmaceutically acceptable salt, polycrystalline form, and application thereof

Crystalline forms of N-[2-(3-Hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)-2H-indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide

Salts of an epidermal growth factor receptor kinase inhibitor

Polymorphic forms of 3-[(2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acrylamide and uses thereof

CRYSTALLINE CALCIUM SALT OF (S)-2-(DIPHENYLACETYL)-1,2,3,4-TETRAHYDRO-6-METHOXY-5-(PHENYLMETHOXY)-3-ISOQUINOLINE CARBOXYLIC ACID

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

CRYSTALLINE FORM OF y-AMINOBUTYRIC ACID ANALOG

Extract effective in treating drug addiction and preparation method therefor

Crystalline forms

Process for the preparation of 2-pyrazolo[1,5-a]pyrazin-2-ylpyrido[1,2-a]pyrimidin-4-one compounds

Process for preparation of Darunavir

Inhibitors of the menin-MLL interaction

(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyrazolo[1,5-a]pyrimidin-7-yl)amino)piperidine-1-carboxylate for inhibiting CDK7

Production method of thiazole derivative

Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide

Synthesis of indazoles

Salts of indazole derivative and crystals thereof

Polymorph of benzamide compound and preparation method and applications thereof

Crystalline form of selexipag

Solid form of (−)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst